Here's this month's Aurum Deal Compass.
View this email in your browser

Dear <<First Name>>,

Welcome to the Aurum Deal Compass, the monthly newsletter provided to you connected with our news and updates. 

We hope you enjoy this newsletter. Contact us for any questions, or feedback.

Thanks for your time,
The Aurum Team
Deal of the Month 

Dr. Reddy’s Laboratories (Dr. Reddy’s or DRL) has signed a definitive agreement with Teva Pharmaceutical Industries (Teva) and an affiliate of Allergan plc to acquire a portfolio of eight Abbreviated New Drug Applications (ANDAs) in the U.S. for USD 350mn in cash.

The Transaction
Through this transaction DRL will acquire a portfolio of eight ANDAs comprised of one approved and seven under review with FDA. Majority of the molecules being acquired are complex products and/or expected to have limited competition. These complex generics are across multiple dosage forms with combined revenue of the branded versions at USD 3.5bn. DRL is acquiring the portfolio on a cash-free, debt-free basis and expects to finance the transaction using a combination of cash on hand and available borrowings.

The acquisition is contingent on the closing of the Teva/Allergan generics transaction and approval of DRL as a buyer by the U.S. Federal Trade Commission.

Click here to learn more about this deal.. 

Disclaimer: Aurum Equity Partners LLP was not a part of this deal in any way. 

Save The Date!

29th July 2016

Restructuring : Impact of Bankruptcy and Insolvency Laws on Banking Sector NPA Resolution
Speaker: Sanjay Bansal
Founder & Managing Partner
Aurum Equity Partners LLP
Get ready for Aurum CXO Dialogues - Webinars this Month!

Join the Aurum CXO Dialogues webinar on Friday, 29th July 2016 at 4 PM.

Evolving Healthcare Delivery in India:
From Hospitals to Home

By Nandini Agarwal
Published: 30th June 2016
Technological advances are influencing our lives in unprecedented ways. Be it shopping apparel in the comfort of home or getting groceries delivered at doorsteps or finding a yoga instructor – old means of availing goods and services are evolving rapidly. A newer addition to this ‘on-demand’ and ‘at convenience’ suite of services, is healthcare coming home – popularly known as ‘In-home Healthcare Market’. In-home health is about bringing essential patient care and health services to people at the convenience of their home.

The SaaS Juggernaut: Advantage India

By Arvind Yadav
Published: 17th June 2016
An Indian software company serving majorly clients in the US or Europe is not an unusual thing anymore. However, if anybody were to guess the location of the India office, a company that counts amongst its clients about 100,000 small businesses globally, they would most probably chose Bangalore or Hyderabad. However, Appointy, which is an advanced web-based scheduling software tool and has around 90,000 salons, spas, and dance and yoga classes as its clients in 100 countries does it out of Bhopal.

Continue Reading..

Impact of Bharat Stage-VI norms on the Indian Auto & Auto Component Industry

By Ketan Salhotra
Published: 6th June 2016
India has the most polluted cities in the world. 30 Indian cities figure in the Top 100 Most Polluted Global Cities (in terms of particulate matter PM10) as per data published by World Health Organization in May 2016. Air pollution is the fifth leading cause of death in India. India has traditionally been a laggard in terms of enforcing and implementing emission norms for the manufacturing sector. Indian auto industry is not an exception to this either.

Continue Reading..

Perspectives on the comparison of India and China's Solar power growth and targets

By Arvind Yadav
Published: June 2016
India’s solar ambitions took a severe blow in February when, in a ruling by World Trade Organization (WTO), the panel found that the Domestic Content Requirement (DCR) imposed under India’s national solar program is inconsistent with its treaty obligations under the global trading regime. This may turn out to be critical for India’s plans to achieve 100 GW of solar capacity, especially when the industry is already suffering from a crash in prices of solar panels in the global market, diminishing of demand in foreign countries.

Continue Reading..
Copyright © 2016 Aurum Equity Partners LLP, All rights reserved.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by MailChimp